Lund University Bioscience is a Lund-based venture capital company founded in 2004.
Lund University Bioscience (LU Bio), is a holding company and venture capital firm partially owned by Lund University in Lund, Sweden.
LU Bio was established to satisfy the need to transform high-end research results and innovations into business propositions, startups and companies through supporting researchers. they are an early-stage investor and provide both capital and industrial expertise to enable a fast and efficient development of bioscience inventions.
Lund University Bioscience has invested in Cytoguide and ProNoxis.
Lund University Bioscience (LU Bio), is a holding company and venture capital firmventure capital firm partially owned by Lund University in Lund, Sweden.
LU Bio was established to satisfy the need to transform high-end research results and innovations into business propositions, startups and companies through supporting researchers. they are an early-stage investor and provide both capital and industrial expertise to enable a fast and efficient development of bioscience inventions.
Lund University Bioscience has invested in Cytoguide and ProNoxis.
Lund University Bioscience (LU Bio), is a holding company and venture capital firm partially owned by Lund University in Lund, Sweden.
LU Bio was established to satisfy the need to transform high-end research results and innovations into business propositions, startups and companies through supporting researchers. they are an early-stage investor and provide both capital and industrial expertise to enable a fast and efficient development of bioscience inventions.